TY - JOUR
T1 - 3D bioprinting for engineering complex tissues
AU - Mandrycky, Christian
AU - Wang, Zongjie
AU - Kim, Keekyoung
AU - Kim, Deok Ho
N1 - Funding Information:
This work was supported by a National Institutes of Health R21 Grant ( R21AR064395 ) and a Muscular Dystrophy Association Research Grant ( MDA255907 ). This work was also supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant (Application No. RGPIN-2014-04010 )
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Bioprinting is a 3D fabrication technology used to precisely dispense cell-laden biomaterials for the construction of complex 3D functional living tissues or artificial organs. While still in its early stages, bioprinting strategies have demonstrated their potential use in regenerative medicine to generate a variety of transplantable tissues, including skin, cartilage, and bone. However, current bioprinting approaches still have technical challenges in terms of high-resolution cell deposition, controlled cell distributions, vascularization, and innervation within complex 3D tissues. While no one-size-fits-all approach to bioprinting has emerged, it remains an on-demand, versatile fabrication technique that may address the growing organ shortage as well as provide a high-throughput method for cell patterning at the micrometer scale for broad biomedical engineering applications. In this review, we introduce the basic principles, materials, integration strategies and applications of bioprinting. We also discuss the recent developments, current challenges and future prospects of 3D bioprinting for engineering complex tissues. Combined with recent advances in human pluripotent stem cell technologies, 3D-bioprinted tissue models could serve as an enabling platform for high-throughput predictive drug screening and more effective regenerative therapies.
AB - Bioprinting is a 3D fabrication technology used to precisely dispense cell-laden biomaterials for the construction of complex 3D functional living tissues or artificial organs. While still in its early stages, bioprinting strategies have demonstrated their potential use in regenerative medicine to generate a variety of transplantable tissues, including skin, cartilage, and bone. However, current bioprinting approaches still have technical challenges in terms of high-resolution cell deposition, controlled cell distributions, vascularization, and innervation within complex 3D tissues. While no one-size-fits-all approach to bioprinting has emerged, it remains an on-demand, versatile fabrication technique that may address the growing organ shortage as well as provide a high-throughput method for cell patterning at the micrometer scale for broad biomedical engineering applications. In this review, we introduce the basic principles, materials, integration strategies and applications of bioprinting. We also discuss the recent developments, current challenges and future prospects of 3D bioprinting for engineering complex tissues. Combined with recent advances in human pluripotent stem cell technologies, 3D-bioprinted tissue models could serve as an enabling platform for high-throughput predictive drug screening and more effective regenerative therapies.
KW - 3D printing
KW - Bioink
KW - Bioprinting
KW - Drug screening
KW - Hydrogel
KW - Regenerative medicine
KW - Tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=84951986383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951986383&partnerID=8YFLogxK
U2 - 10.1016/j.biotechadv.2015.12.011
DO - 10.1016/j.biotechadv.2015.12.011
M3 - Review article
C2 - 26724184
AN - SCOPUS:84951986383
SN - 0734-9750
VL - 34
SP - 422
EP - 434
JO - Biotechnology Advances
JF - Biotechnology Advances
IS - 4
ER -